How to become a dealer

If you are interested in becoming our dealer
please contact us

Apply the form




EC Declaration of Conformity Annex (List B)

EC Declaration of Conformity Annex (Others)


20/13, b.2,
Sadovnicheskaya str.
Moscow, Russia, 115035

Phone: +7 (495) 664 2884
Fax: +7 (495) 664 2889
+7 (495) 664 28 84
News & Articles About ILS Our products Advertising materials Contact us

Company news

Extension of range of Hepatitis C virus PCR diagnostic kit, Dec.2012

Dear colleagues,

We are pleased to inform you about new hepatitis C virus (HCV) genotypes differentiation PCR kit. The kits of these series intend for an in vitro nucleic acid amplification test for qualitative detection and differentiation of hepatitis C virus (HCV) genotypes in the clinical materials (peripheral blood plasma) by means of real-time hybridization-fluorescence detection.

New! AmpliSens® HCV-genotype-FRT-g1-6 is intended to detect HCV genotypes 1a, 1b, 2, 3a, 4, 5a, and 6.

The variant AmpliSens HCV-genotype-FRT-g1-4 is intended to detect HCV genotypes 1a, 1b, 2, 3a, and 4.

AmpliSens HCV-genotype-FRT PCR kit is recommended for use after detection of hepatitis C virus RNA by qualitative or quantitative analysis with the use of PCR kits manufactured by FBIS CRIE (for example, AmpliSens HCV-FRT (real-time hybridization-fluorescence detection), AmpliSens HCV-FEP (end-point hybridization-fluorescence detection), or AmpliSens HCV-EPh (electrophoretic detection in agarose gel).

The results of PCR analysis are taken into account in complex diagnostics of disease.

Back to the news list